Stage set for larger study The Side-Out Basis&39.

For all 25 patients, the therapy selected based on their tumor evaluation was different than what they would have obtained in their next planned treatment, if they had not participated in the study. The Virginia G. Piper Malignancy Center at Scottsdale Health care was the lead site in the 2- – year pilot study. Furthermore, patients in the study had been treated at Virginia Malignancy Specialists, US Oncology, in Fairfax, Vir.; and at Evergreen Hematology & Oncology in Spokane, Wash. Translational Drug Advancement , a TGen organization, managed the pilot medical trial, and will also oversee the follow-on study, Side-Out II. ‘This was an exciting study for TD2,’ said Linda Vocila, BSN, RN, Director of Clinical Operations at TD2 and co-author of the study.Something real has happened to me. You can read the man’s full story at You can find out about the task of Dr also. Mary Newport, and how coconut oil may be able to help you or a loved one experience rest from degenerative disease or dementia, at

Cigna, PAMF start collaborative accountable care initiative Cigna and the Palo Alto Medical Base , a not-for-profit health care organization that is clearly a pioneer in the multispecialty group practice of medicine, have launched a collaborative accountable care initiative to expand patient usage of healthcare, improve care coordination, and obtain the ‘triple aim’ of improved wellness outcomes , lower total medical costs and elevated patient satisfaction.